Your browser doesn't support javascript.
loading
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.
Ho, A D; Verkerke, H; Allen, J W; Saeedi, B J; Boyer, D; Owens, J; Shin, S; Horwath, M; Patel, K; Paul, A; Wu, S-C; Chonat, S; Zerra, P; Lough, C; Roback, J D; Neish, A; Josephson, C D; Arthur, C M; Stowell, S R.
Afiliação
  • Ho AD; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA , and Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA.
  • Verkerke H; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA , and Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA.
  • Allen JW; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA , and Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA.
  • Saeedi BJ; Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Boyer D; Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Owens J; Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Shin S; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Horwath M; Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Patel K; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA.
  • Paul A; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA.
  • Wu SC; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School , Boston, MA.
  • Chonat S; Department of Pediatrics, Emory University School of Medicine , Atlanta, GA.
  • Zerra P; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Lough C; Lifesouth Blood Donation Services , Gainesville, FL.
  • Roback JD; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Neish A; Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Josephson CD; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Arthur CM; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, GA.
  • Stowell SR; Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine , 201 Dowman Drive, Atlanta, GA 30322 , and Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical S
Immunohematology ; 37(1): 33-43, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33962490
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Immunohematology Assunto da revista: ALERGIA E IMUNOLOGIA / HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Marrocos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Immunohematology Assunto da revista: ALERGIA E IMUNOLOGIA / HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Marrocos